Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Malignant Lymphoma

Free Subscription 20.04.2026 2 Am J Hematol 1 Am J Surg Pathol 3 Blood 1 BMC Neurol 1 Bone Marrow Transplant 1 Br J Dermatol 4 Br J Haematol 1 Cancer 1 Eur J Haematol 2 Haematologica 1 Int J Cancer 1 J Am Acad Dermatol 1 J Clin Oncol 1 J Natl Cancer Inst 2 Leukemia 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Hematol

1. YAN F, Liu Y, Lee HH, Wang W, et al
   Dissecting Pirtobrutinib Resistance in Mantle Cell Lymphoma Through Single-Cell Multi-Omics.
   Am J Hematol. 2026 Apr 17. doi: 10.1002/ajh.70304.
   PubMed         Abstract available
   
   
2. GUGLIOTTA G, Argnani L, Cantelli M, Pinto A, et al
   A Real-Life Multicenter Study of Checkpoint Inhibitors in Relapsed/Refractory Primary Mediastinal B-Cell Lymphoma.
   Am J Hematol. 2026 Apr 10. doi: 10.1002/ajh.70317.
   PubMed         Abstract available
   
   

   
   Am J Surg Pathol

3. BULTERYS P, Zhou CW, Gong S, Gars E, et al
   Clinicopathologic and Molecular Characteristics of Merkel Cell Polyomavirus Positive T-Cell Lymphoproliferative Disorders.
   Am J Surg Pathol. 2026;50:481-500.
   PubMed         Abstract available
   
   

   
   Blood

4. SCHORB E
   Mapping risk and therapy in secondary CNS lymphoma.
   Blood. 2026;147:1783-1784.
   PubMed        
   
   
5. VODICKA P, El-Galaly TC, Prochazka V, Flowers CR, et al
   Diagnosis-to-Treatment Interval Is Associated With Outcomes in Follicular Lymphoma Treated with Immunochemotherapy.
   Blood. 2026 Apr 14:blood.2026033090. doi: 10.1182/blood.2026033090.
   PubMed         Abstract available
   
   
6. STEVENSON FK, Stamatopoulos K
   The singularity of IGHV4-34 links infection, autoimmunity, and B-cell tumors.
   Blood. 2026;147:1793-1803.
   PubMed         Abstract available
   
   

   
   BMC Neurol

7. KHAND Y, Garg I, Agyei P, Galvez-Jimenez N, et al
   Exploring a possible shared pathophysiology in co-occurrence of multiple sclerosis and Hodgkin lymphoma: a case report and review of literature.
   BMC Neurol. 2026 Apr 13. doi: 10.1186/s12883-026-04889.
   PubMed        
   
   

   
   Bone Marrow Transplant

8. LI J, Feng S, Jia S, Zhang Y, et al
   Sequential CD19/CD22 CAR-T cell therapy following ASCT shows improved efficacy versus CAR-T alone in relapsed/refractory large B-cell lymphoma.
   Bone Marrow Transplant. 2026 Apr 14. doi: 10.1038/s41409-026-02858.
   PubMed        
   
   

   
   Br J Dermatol

9. KHOSHNIYATI S, Fleischli A, Niknejad K, Weiner J, et al
   The prognostic impact of prior atopic dermatitis on cutaneous T-cell lymphoma: a single-center retrospective cohort study.
   Br J Dermatol. 2026 Apr 16:ljag143. doi: 10.1093.
   PubMed        
   
   

   
   Br J Haematol

10. MARTINS F, Calvao J
    Mycosis fungoides and Sezary syndrome.
    Br J Haematol. 2026;208:1207-1210.
    PubMed         Abstract available
    
    
11. TIAN Z, Deng Z, Han F, Yu L, et al
    An AI-based IHC quantification technique for assisting in the differentiation of MCL from CLL/SLL.
    Br J Haematol. 2026;208:1287-1295.
    PubMed         Abstract available
    
    
12. ARAI Y, Jo T, Sato T, Sakurai M, et al
    Decreased renal function predicts severe cytokine release syndrome after CAR-T-cell therapy for large B-cell lymphoma.
    Br J Haematol. 2026 Apr 15. doi: 10.1111/bjh.70488.
    PubMed         Abstract available
    
    
13. VALCARCEL B, Utsunomiya A, Otsuka M, Miyahara M, et al
    Distribution of adult T-cell leukaemia/lymphoma subtypes and survival outcomes across geographical regions: An international retrospective cohort study.
    Br J Haematol. 2026 Apr 15. doi: 10.1111/bjh.70494.
    PubMed         Abstract available
    
    

    
    Cancer

14. AKKAD N, Chen M, Nguyen S, Romero A, et al
    Assessing patient perspectives on enrollment in lymphoma clinical trials.
    Cancer. 2026;132:e70377.
    PubMed         Abstract available
    
    

    
    Eur J Haematol

15. KARHU A, Aronen S, Ronka A, Sunela K, et al
    Low Risk of Central Nervous System Relapse Among Patients With T-Cell/Histiocyte-Rich Large B-Cell Lymphoma Despite High-Risk Disease Presentation.
    Eur J Haematol. 2026 Apr 13. doi: 10.1111/ejh.70190.
    PubMed         Abstract available
    
    

    
    Haematologica

16. KERSTEN MJ, Dreyling M, Linton KM, Chitu D, et al
    Lenalidomide-rituximab or lenalidomide-rituximab-bendamustine for relapsed/refractory follicular lymphoma: primary and final analysis of the randomized phase II HOVON110/ReBeL study.
    Haematologica. 2026 Apr 16. doi: 10.3324/haematol.2025.300152.
    PubMed         Abstract available
    
    
17. MIYAGI S, Mori K, Miyawaki K, Shimo M, et al
    Gene expression profile of adult T-cell leukemia/lymphoma with human T-cell lymphotropic virus type 1-infected Hodgkin and Reed-Sternberg-like cells is more similar to classic Hodgkin lymphoma than typical adult T-cell leukemia/lymphoma.
    Haematologica. 2026 Apr 16. doi: 10.3324/haematol.2025.289270.
    PubMed         Abstract available
    
    

    
    Int J Cancer

18. ZIEL-SWIER LJYM, Rassek K, Liu Y, Seitz A, et al
    The Growth Supporting Role of ZDHHC11 Is Linked to the MEF2B-BCL6 Regulatory Circuit in Burkitt Lymphoma.
    Int J Cancer. 2026 Apr 16. doi: 10.1002/ijc.70506.
    PubMed         Abstract available
    
    

    
    J Am Acad Dermatol

19. KHOSHNIYATI S, Bui T, Sterling CH, Rozati S, et al
    Pembrolizumab in Heavily Pretreated and Refractory Cutaneous T-Cell Lymphoma: A Single-Center Study.
    J Am Acad Dermatol. 2026 Apr 13:S0190-9622(26)00553.
    PubMed        
    
    

    
    J Clin Oncol

20. LEONARD JP, Trneny M, Zhang H, Nowakowski GS, et al
    Lenalidomide Plus Rituximab for Relapsed/Refractory Indolent Non-Hodgkin Lymphoma: 5-Year Follow-Up and Subgroup Analyses From the Phase III AUGMENT Trial.
    J Clin Oncol. 2026 Apr 16:JCO2501770. doi: 10.1200/JCO-25-01770.
    PubMed         Abstract available
    
    

    
    J Natl Cancer Inst

21. LAMMERS EM, Zijlstra JM, Schaapveld M, Haagsma JA, et al
    The impact of survivorship care on burden of disease among Hodgkin lymphoma survivors.
    J Natl Cancer Inst. 2026 Apr 11:djag080. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Leukemia

22. LIU Y, Chen R, Gao X, Zhu F, et al
    PRMT5 inhibition sensitizes B-cell lymphoma cells to ferroptosis.
    Leukemia. 2026 Apr 17. doi: 10.1038/s41375-026-02932.
    PubMed         Abstract available
    
    
23. TAVAROZZI R, Maher N, Catania G, Zacchi G, et al
    Evolving therapeutic strategies in mantle cell lymphoma: advancements and future directions.
    Leukemia. 2026 Apr 15. doi: 10.1038/s41375-026-02942.
    PubMed         Abstract available
    
    

    
    PLoS One

24. 
    Retraction: A transcriptional signature associated with non-Hodgkin lymphoma in the blood of patients with Q fever.
    PLoS One. 2026;21:e0347091.
    PubMed        
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum